tiprankstipranks
Advertisement
Advertisement
Radiopharm Unveils Encouraging First-in-Human Data for HER2 Radiopharmaceutical 177Lu-RAD202
PremiumCompany AnnouncementsRadiopharm Unveils Encouraging First-in-Human Data for HER2 Radiopharmaceutical 177Lu-RAD202
2M ago
Radiopharm completes U.S. Phase 2b enrolment for RAD 101 brain metastasis imaging trial
Premium
Company Announcements
Radiopharm completes U.S. Phase 2b enrolment for RAD 101 brain metastasis imaging trial
2M ago
Radiopharm gets DSMC recommendation to advance 177Lu-RAD202 to next dose
Premium
The Fly
Radiopharm gets DSMC recommendation to advance 177Lu-RAD202 to next dose
2M ago
Radiopharm’s RAD101 Hits 90% Concordance in Phase 2b Brain Metastases Trial
PremiumCompany AnnouncementsRadiopharm’s RAD101 Hits 90% Concordance in Phase 2b Brain Metastases Trial
3M ago
Radiopharm Theranostics to spotlight oncology pipeline at NWR Virtual Healthcare Conference
Premium
Company Announcements
Radiopharm Theranostics to spotlight oncology pipeline at NWR Virtual Healthcare Conference
3M ago
Radiopharm Theranostics Narrows Asset Base as Half-Year Loss Widens, Increases Stake in MD Anderson JV
Premium
Company Announcements
Radiopharm Theranostics Narrows Asset Base as Half-Year Loss Widens, Increases Stake in MD Anderson JV
4M ago
Radiopharm’s New Phase 1 Imaging Trial Puts LRRC15-Targeted Radiotherapy in Focus
PremiumCompany AnnouncementsRadiopharm’s New Phase 1 Imaging Trial Puts LRRC15-Targeted Radiotherapy in Focus
5M ago
Radiopharm increases ownership in Radiopharm Ventures to 87.5%
Premium
The Fly
Radiopharm increases ownership in Radiopharm Ventures to 87.5%
5M ago
Radiopharm Theranostics Options Lapse, Trimming Potential Dilution
Premium
Company Announcements
Radiopharm Theranostics Options Lapse, Trimming Potential Dilution
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100